ClinicalTrials.gov
ClinicalTrials.gov Menu

Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01389310
Recruitment Status : Completed
First Posted : July 8, 2011
Last Update Posted : December 23, 2014
Sponsor:
Collaborator:
PENTA Foundation
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2014
  Actual Study Completion Date : February 2014